Hematogenous infection with the yeast Candida albicans now occurs with increasing frequency in the neonate, the immunocompromised patient, and the hyperglycemic or hyperalimented host. Yeast-phase C. albicans expresses a protein that is antigenically and structurally related to CD11b/CD18, a member of the 2 integrins and a well-characterized adhesin for mammalian neutrophils. Both the neutrophil protein and its analogue in C. albicans have an identical affinity for the C3 ligand iC3b, and both proteins are significantly increased in expression at 370C. Given these several similarities, we therefore studied the role of the integrin analogue on C. albicans in the adhesion of the yeast to human umbilical vein endothelium (HUVE).
Introduction
The yeast Candida albicans, a normal inhabitant ofthe human gastrointestinal tract, has emerged as a leading pathogen in the neonate, the immunocompromised patient, and the hyperglycemic or hyperalimented host (1) (2) (3) . Invasive disease usually arises from endogenous sources (4, 5) ; in animal models of invasive disease, pathogenicity ofcandidal strains in vivo correlates directly with yeast adhesion in vitro (6) . To understand whether the ability of the yeast to adhere to host tissues or to components of extracellular matrix is fundamental to the pathogenesis ofinvasive candidal infection, the mechanisms of this process must be further clarified.
Several investigations have examined factors in the yeast and in the host that influence adhesion of C. albicans (for review see reference 7) . All studies concur that viable C. albicans adhere more actively than do heat-or ultraviolet-killed yeasts (8) (9) (10) (11) . Transformation from the yeast phase to the mycelial phase is also correlated with increased adhesion (7, 10) . Elevated concentrations of glucose in saliva or vaginal fluids dramatically increase the ability of candida to adhere or to replicate actively at local tissue sites (12, 13) ; indeed, in one study, increased concentrations of salivary glucose in diabetic patients were the single most important influence upon candidal replication ( 12) .
Current information indicates that adhesion moieties on the yeast are expressed on the cell surface (8) (9) (10) (11) (14) (15) , are most likely glycoproteins because oftheir sensitivity to proteolytic enzymes and reducing agents (8-1 1), and typically contain some mannan (14, 16) . Although the use of nonstandardized matrices such as swabbed specimens from oral or vaginal mucosa has led to widely varying results, the development of reproducible assays that quantitate adhesion of yeast to wellcharacterized cell lines is an important first step in defining these mechanisms (17) .
We have recently described a surface protein on yeastphase C. albicans that shares antigenic and structural homology with the a-subunit of the leukocyte adhesion glycoprotein CD1 lb/CD 18, also known as Mol, Mac-l, the iC3b receptor, or complement receptor type 3 (CR3); CD1 lb/CD 18 is found on mammalian neutrophils, monocytes, and macrophages (18) (19) (20) (21) . MAbs that recognize the a subunit of CD1 lb/CD 18 bind specifically to yeast-or hyphal-phase C. albicans, while isotype controls do not (18) (19) 22) . Increases in ambient temperature to 37°C result in increased expression of CDl lb/ CD1 8 in the neutrophil and of its analogue in C. albicans (18, (23) (24) do not bind specifically to C. albicans, as assessed by flow cytometry or fluorescent microscopy (18, 19, 22) . After a 30-min incubation on ice with murine MAb, yeasts were centrifuged and washed three times with PBS/0.02% azide. Yeasts were then incubated on ice for 30 min with a 1:20 dilution of goat F(ab')2 antibody to mouse IgM/IgG conjugated to fluorescein isothiocyanate (Tago Inc., Burlingame, CA). For fluorescent microscopy, 2 X 10' CFU were incubated in suspension with anti-Mo 1-94 or mouse IgM as described above and adhered to microscope slides coated with 0.6% agarose; phase contrast and immunofluorescent microscopy were performed on a fluorescent microscope (Laborlux 12; E. Leitz, Inc., Rockleigh, NJ) at x400 (Fig. 1 (28) Following the incubation period the wells were washed three times with HBSS++/BSA to remove nonadherent yeasts; these were counted in a scintillation counter (LS230; Beckman Instruments, Inc., Palo Alto, CA). Adherent cells were removed with a commercial preparation of trypsin/EDTA (Life Technologies, Inc.), solubilized in 0.5 M NaOH, and counted. Loss ofyeast cells was < 10%b oftotal cpm. Total adhesion was calculated from the following formula: rCPM(,dhmebt) X 100. cpm(ttJ e)J Specific adhesion was calculated as the difference between total adhesion and nonspecific adhesion, the latter measured in the presence of 100-fold excess unlabeled C. albicans. Adhesion was also verified microscopically; yeast phase was maintained throughout, and agglutination was not observed, either by direct vision or by microscopy.
Inhibition of adhesion with MAb. C. albicans were grown in the defined medium plus 20 mM D-glucose as described above and were then incubated in suspension with 300 Mg/ml anti-Mo 1-94, 300 Mg/ml MAb 44 (IgG2,), or 300 Mg/ml MAb 17 (IgM) for 30 min at 4°. Yeasts were then pelleted and used in the adhesion assay as described above.
Purification ofiC3b. iC3b was isolated after proteolysis of purified human C3 according to our published methods (25) . Briefly, human C3 was isolated from fresh plasma after affinity chromatography on Sepharose L-lysine, ion exchange chromatography on DEAE-Sephacel, and sizing chromatography on Sepharose CL-6B, according to the method of Tack et al. (29) . Possible trace contaminants, C5, IgG, or 1. Abbreviation used in thispaper: HUVE, human umbilical vein endothelium.
IgA, were removed by passage of purified C3 over CNBr-Sepharose 4B (Pharmacia) that had been coupled to antibodies to C5, IgG, and IgA. Antibodies to human complement proteins H and I were isolated from goat antisera, the kind gift of Dr. Brian F. Tack (Scripps Clinic, LaJolla, CA), after caprylic acid precipitation (30) and coupled to CNBr Sepharose 4B (Pharmacia) for use in affinity purification ofFactors H and I from fresh human serum. Factors H and I were eluted from their respective affinity columns with 3 M KSCN/1 50 mM NaCl/ 100 mM Tris, pH 8.0. Purified Factor H yielded a single band of 150 kD on 10% SDS-PAGE under reducing conditions; Factor I yielded a single band of 105 kD.
After cleavage ofC3 to C3b by 0. 15% wt/wt L-I-tosylamide-2-phenylethyl chloromethyl ketone trypsin (Millipore Continental Water Systems, Bedford, MA) at 370C, the reaction was halted by a 20-fold molar excess of soybean trypsin inhibitor (Worthington Biochemical Corp., Freehold, NJ). After precipitation with 15% wt/vol polyethylene glycol (Sigma Chemical Co., St. Louis, MO), the protein was then resuspended in 0.05 M Na acetate/1.0 M NaCI, pH 5.6, and chromatographed on a 2.5 x 100-cm Sephacryl S-300 column (Pharmacia 200 Ad. Duration ofthe incubation and experimental conditions oftemperature, washing, and release were identical to those described above in the adhesion assay.
Statistics. Results, which are expressed as mean±standard error unless otherwise noted, were analyzed using the Student's t test for paired samples when comparing expression ofthe iC3b receptor and adhesion of glucose-and glutamate-grown organisms; the Student's t test for unpaired samples was used for inhibition studies. P < 0.05 was considered significant.
Results
Fluorescent microscopy ofC. albicans. Fig. 1 345 .0±7.0 after growth in 1-glucose; P< 0.00 1). These changes were highly significant at each comparison. Time course ofadhesion of C. albicans. Fig. 2 graphs the adhesion ofa blood isolate of C. albicans as a function oftime. Specific adhesion, calculated as the difference between total adhesion and nonspecific adhesion, was maximal at 60 min, which was therefore chosen as the incubation time for subsequent experiments.
Effect ofglucose on receptor expression and adhesion in C Effect ofanti-CDJlb/CD18 MAbs on adhesion of C. albicans. As shown in Table III , MAbs that recognize epitopes on the a-subunit of CD I lb/CD 18 on the mammalian neutrophil bound to blood and urinary isolates of C. albicans in a manner independent of isotype. Fig. 4 displays the ability of several MAbs to inhibit the glucose-enhanced adhesion of C. albicans to HUVE. The IgM MAb anti-Mol-94 had no effect on the specific adhesion of C. albicans to endothelium, even when its concentration was increased threefold; this MAb has been shown by others to be less effective in blocking adhesion-dependent functions in the neutrophil (31 dard error for n = 4 ex-
(IgM) periments.
( Fig. 5) . This change was highly statistically significant (P < 0.001). These results indicate that a substantial proportion of the adhesion of C. albicans to HUVE is mediated by the integrin analogue and can be inhibited by blockade with its specific ligand.
Discussion
The Mean channel fluorescence provides perhaps the best measure ofthe density ofthe integrin analogue per individual yeast cell. As shown in Fig. 3 , enhancement ofthe expression ofthis protein after growth of C. albicans in 1-glucose (top panel) correlated with increased yeast adhesion to HUVE (bottom panel). This effect also occurred with a urinary isolate of C. albicans. In absolute terms, adhesion of the blood isolate rose from 20% to 36% and that of the urinary isolate from 38% to 49% after growth in D-glucose. These observations suggest that specific adhesion is dependent not only upon the expression of the integrin analogue on the yeast surface, but also upon the availability of binding sites on the endothelial cell or in the subendothelial matrix.
The endothelial cell and its surrounding matrix display several potential ligands that may serve to attach the integrin analogue on C. albicans. Synthesis ofC3 by endothelial cells is well described (32) ; the degradation of this protein by serum or cellular proteinases may provide a local source of iC3b at the endothelial surface that serves to attach C. albicans to endothelium. Because iC3b contains the sequence arginine-glycineaspartic acid (RGD), this tri-peptide may be important in mediating candidal adhesion, as it is for integrin-mediated adhesion on mammalian cells (33, 34) . Alternatively, RGDcontaining subendothelial matrix components, such as fibronectin or laminin, may promote adhesion in vivo. For example, exposure of the subendothelial matrix by pharmacologic contraction ofcultured endothelial cells increased the adhesion of C. albicans (35) .
Additional support for the involvement of the candidal integrin in adhesion derives from the recent description of an avirulent mutant of C. albicans, that has reduced binding of iC3b-coated, but not C3d-coated, sheep erythrocytes (36) . However, neither the binding of anti-Mo 1-94 nor adhesion to human endothelial cells was studied with this mutant.
Preliminary results indicate that ICAM-1, an endothelial surface molecule, may not be involved, because upregulation of ICAM-1 by activation of HUVE with tumor necrosis factor did not increase yeast adhesion (Hostetter, M. K., and G. M. Vercellotti, unpublished observations). This latter observation is supported by the recent report that CDl lb/CD 1 8 on neutrophils fails to recognize ICAM-l on HUVE (37) .
Three MAbs directed against specific epitopes ofthe a subunit of CDl lb/CD 1 Lastly, the substantial inhibition of adhesion after preincubation ofyeast cells with iC3b, an RGD-containing ligand specific for CDl lb/CD 1 8, provides more definitive evidence of the participation of the integrin analog in yeast adhesion. Clearly, our results do not exclude a role for other surface interactions that may also be implicated in candidal adhesion; for example, candidal surface structures capable of interacting with fibronectin, fibrinogen, or laminin may account for that portion of adhesion that could not be inhibited by iC3b (40) . Nonetheless, our results indicate that the integrin analogue in C. albicans is responsible for nearly 50% ofthe adhesion ofthis yeast to HUVE.
The presence of an integrin-like protein in C. albicans has been shown in separate studies to subvert opsonization and to inhibit phagocytosis of the yeast, by virtue of its competition with the iC3b receptor on the neutrophil (18, 19) . This effect may be a fortuitous consequence ofits mimicry ofa phagocytic receptor. The experiments ofthis paper establish a more fundamental function: to allow the yeast to adhere to host tissues and thereby gain a foothold for potential invasion. Because of the morbidity of C. albicans infections ofthe urinary tract, gastrointestinal tract, integument, and vascular tree, the role of the integrin analogue in adhesion of the yeast to epithelial and mucosal surfaces, or even to synthetic polymers such as silastic, should be thoroughly investigated. Blockade ofthe initial point of contact between yeast and host by inhibition of adhesion might well avert invasive candidal infections.
Inhibition of adhesion by MAbs 44 and 17 indicates not only a remarkable. degree of homology between adhesive epitopes of yeast and neutrophil proteins, but also an intriguing phylogenetic similarity. In other studies, polyclonal antibodies to the conserved cytoplasmic domain ofthe integrin fB subunit detected cross-reactive proteins on C. albicans (41) , while other work has shown that numerous MAb directed against the 12 class of integrins, the leukocyte adhesion glycoproteins, also recognized candidal proteins (18, 19, 22) . Thus, the yeast protein that we have identified may well be a precursor of mammalian integrins. A definitive statement of phylogenetic relationship must await sequencing of the entire protein, which is well underway.
